Cell Signaling Technology

Eg5 (4H3-1F12) Mouse Monoclonal Antibody

#4203 · $159,348

100
Citing papers
10.6k
Combined citations
Supplier page Find this product

Research areas

Cancer Cells and Metastasis10MicroRNA in disease regulation6Pluripotent Stem Cells Research6Autophagy in Disease and Therapy6Circular RNAs in diseases5Cancer-related molecular mechanisms research5Endoplasmic Reticulum Stress and Disease5Immune Response and Inflammation5

Papers citing this product

1
Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney
Journal of Clinical Investigation·2005·556 cit.·DOI
2
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer
Molecular Cancer·2018·366 cit.·DOI
3
Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
American Journal Of Pathology·2012·323 cit.·DOI
4
The <i>Helicobacter pylori</i> Vacuolating Toxin Inhibits T Cell Activation by Two Independent Mechanisms
The Journal of Experimental Medicine·2003·303 cit.·DOI
5
Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells
International Journal of Nanomedicine·2017·278 cit.·DOI
6
Homocysteine directly interacts and activates the angiotensin II type I receptor to aggravate vascular injury
Nature Communications·2017·255 cit.·DOI
7
An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice
Journal of Clinical Investigation·2008·250 cit.·DOI
8
Neuroprotective and Axon Growth-Promoting Effects following Inflammatory Stimulation on Mature Retinal Ganglion Cells in Mice Depend on Ciliary Neurotrophic Factor and Leukemia Inhibitory Factor
Journal of Neuroscience·2009·248 cit.·DOI
9
Cardiopoietic programming of embryonic stem cells for tumor-free heart repair
The Journal of Experimental Medicine·2007·236 cit.·DOI
10
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
Nature Communications·2020·206 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.